The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting
Authors:
- Elisabetta MetafuniElisabetta Metafuni
- Luca Di MarinoLuca Di Marino
- Sabrina GiammarcoSabrina Giammarco
- Silvia BellesiSilvia Bellesi
- Maria Assunta LimongielloMaria Assunta Limongiello
- Federica SoràFederica Sorà
- Filippo FrioniFilippo Frioni
- Roberto MaggiRoberto Maggi
- Patrizia ChiusoloPatrizia Chiusolo
- Simona SicaSimona Sica
Open Access
- 29 August 2023
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 11 (9) , 2182
Abstract
Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host disease. This article aims to review the current knowledge about the close link between microbiota and allogeneic stem cell transplantation setting. The PubMed search engine was used to perform this review. We analyzed data on microbiota dysbiosis related to the above-mentioned affecting factors. We also looked at treatments aimed at modifying gut dysbiosis and applications of fecal microbiota transplantation in the allogeneic stem cell transplant field, with particular interest in fecal microbiota transplantation for graft-versus-host disease (GvHD), multidrug-resistant and clostridium difficile infections, and microbiota restoration after chemotherapy and antibiotic therapy.Keywords
Funding Information
- Centro di ricerca sulle cellule staminali emopoietiche e le terapie cellulari, Università Cattolica del Sacro Cuore
This publication has 102 references indexed in Scilit:
- Clostridium difficile Infection after Adult Autologous Stem Cell Transplantation: A Multicenter Study of Epidemiology and Risk FactorsTransplantation and Cellular Therapy, 2013
- Treg induction by a rationally selected mixture of Clostridia strains from the human microbiotaNature, 2013
- Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstreamEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Immune Response to Bifidobacterium bifidum Strains Support Treg/Th17 PlasticityPLOS ONE, 2011
- Fidaxomicin versus Vancomycin forClostridium difficileInfectionNew England Journal of Medicine, 2011
- Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota compositionClinical and Experimental Immunology, 2010
- A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycinMicrobiology, 2010
- Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantationClinical Transplantation, 2010
- Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProceedings of the National Academy of Sciences, 2010
- Microbial regulation of intestinal radiosensitivityProceedings of the National Academy of Sciences, 2005